What We're Reading: Page 64
Industry reads hand-picked by our editors
Jan 24, 2024
Jan 23, 2024
-
Axios
Unlikely political allies take on drugmakers’ patent tactics
-
Stat
Dana Farber says 6 studies to be retracted and 31 corrected
-
The Wall Street Journal
Obesity Drugs Lead to Muscle Loss—Pharma Companies Want to Fix That
-
Reuters
J&J profit edges past Street view after deals delay Stelara competition
Jan 22, 2024
-
MIT Technology Review
Scientists are finding signals of long covid in blood. They could lead to new treatments.
-
C&EN
Biomanufacturers will pursue small projects to weather the economic storm
-
Reuters
US FDA adds ‘boxed warning’ for Amgen’s bone loss drug Prolia
-
Bloomberg
Evotec Says Former CEO Failed to Report Stock Trades on Time
Jan 19, 2024
Jan 18, 2024
-
The 19th News
Moms are still struggling to get RSV shots for their babies
-
The Wall Street Journal
Drugmakers Raise Prices of Ozempic, Mounjaro and Hundreds of Other Drugs
-
San Francisco Business Times
Bay Area biotech Sangamo puts entire Peninsula headquarters up for sublease
-
ApexOnco
Car-T comes full circle
Jan 17, 2024
-
Politico
Why health care experts are so concerned about fishing boats
-
The Wall Street Journal
Many Cancers Are on the Rise in the U.S., Even as Overall Deaths Fall
-
BioSpace
GSK Raises $1.24B by Selling Stake in Consumer Health Spin-Off Haleon
-
KFF Health News
Trump Official Who OK’d Drugs From Canada Chairs Company Behind Florida’s Import Plan
Jan 16, 2024
-
The Wall Street Journal
Medicare Patients on Pricey Drugs Are Saving Big This Year
-
CNBC
Cancer drugs: Renewed interest in ADCs will continue in 2024
-
Reuters
Trade union opposes possible split-up of Germany’s Bayer
-
AP News
Vivek Ramaswamy suspends his 2024 Republican presidential bid and endorses rival Donald Trump
Previous
